biotechnology
Every Vision, One Solution
-
New Alzheimer's Disease Drug Receives Full FDA Approval
an Alzheimer's disease drug developed by Eisai and Biogen, received conditional approval from the FDA.
an Alzheimer's disease drug developed by Eisai and Biogen, received conditional approval from the FDA.
125,005 Literary Works • 672,797 Reviews